0.3862

4.38% 0.0162

Iterum Therapeutics Plc (ITRM)

Überblick Nachrichten Preisverlauf Financials Warum fällt ITRM? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$0.37

Offen:

$0.39

24-Stunden-Volumen:

826.59K

Relative Volume:

0.91

Marktkapitalisierung:

$20.39M

Einnahmen:

Nettoeinkommen (Verlust:

$-24.08M

KGV:

-0.4505

EPS:

-0.8572

Netto-Cashflow:

$-14.75M

1W Leistung:

-17.85%

1M Leistung:

-47.38%

6M Leistung:

-57.84%

1J Leistung:

-78.18%

1-Tages-Spanne:

$0.3804

$0.41

1-Wochen-Bereich:

$0.3622

$0.4923

52-Wochen-Spanne:

$0.3622

$3.02

Iterum Therapeutics Plc Stock (ITRM) Company Profile

Firmenname

Iterum Therapeutics Plc

Sektor

Healthcare (1129)

Branche

Biotechnology (632)

Telefon

(872) 225-6077

Adresse

3 DUBLIN LANDINGS, DUBLIN 1

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-02-07

Neueste SEC-Einreichungen

ITRM's Discussions on Twitter

Vergleichen Sie ITRM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ITRM Iterum Therapeutics Plc	0.3862	19.53M	0	-24.08M	-14.75M	-0.8572
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-05-28	Hochstufung	Gabelli & Co	Sell → Hold
2021-03-15	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-06-02	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-01-21	Herabstufung	Gabelli & Co	Buy → Sell
2019-12-11	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-06-21	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten

Nov 21, 2025

Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Nov 21, 2025

Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Nov 21, 2025

Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com

Nov 21, 2025

Nov 20, 2025

Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria

Nov 20, 2025

Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView

Nov 20, 2025

[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan

Nov 20, 2025

Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com

Nov 19, 2025

Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025

Published on: 2025-11-19 01:58:59 - newser.com

Nov 19, 2025

Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com

Nov 19, 2025

Nov 18, 2025

Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com

Nov 18, 2025

There is no way Iterum Therapeutics Plc (ITRM) can keep these numbers up - Setenews

Nov 18, 2025

Visualizing Iterum Therapeutics plc stock with heatmaps2025 Year in Review & Expert Verified Movement Alerts - newser.com

Nov 18, 2025

Nov 16, 2025

Will Iterum Therapeutics plc stock split attract more investorsCPI Data & Reliable Breakout Forecasts - newser.com

Nov 16, 2025

Nov 15, 2025

Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 15, 2025